Role of Siglec‐E in MC903 ‐Induced Atopic Dermatitis
Experimental Dermatology · 2025
DOI: 10.1111/exd.70064 ↗At a glance
Journal article in Experimental Dermatology, 2025. Written by Mari Nakanishi and 5 co-authors. Institution: Department of Dermatology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan. Major MEDLINE topics: Dermatitis, Atopic, Antigens, Differentiation, B-Lymphocyte, Sialic Acid Binding Immunoglobulin-like Lectins, Antigens, CD. Cited 1 times so far (Crossref); 54 references. Funded by: Public Promoting Association Asano Foundation for Studies on Medicine, Japanese Ministry of Education, Science, Sports, and Culture.
Abstract (original language)
Atopic dermatitis (AD) is a common skin disease. Although AD pathogenesis has been widely researched, inhibitory mechanisms in AD are still unclear. Sialic acid‐binding immunoglobulin‐like lectins (Siglecs) are a family of receptors recognising sialic acids; most Siglecs work as inhibitory receptors. Among Siglecs, Siglec‐E is expressed on dendritic cells (DCs) and eosinophils, important immune cells in AD. Although Siglec‐E inhibits Type 1 inflammatory diseases, how it influences AD is unknown. Thus, we investigated the role of Siglec‐E in AD mouse model by using Siglec‐E knockout (KO) mice. We demonstrated that Siglec‐E attenuated AD‐like inflammation of mice caused by topical application of MC903 on ear skin (MC903‐induced AD). To reveal the role of Siglec‐E in MC903‐induced AD, we focused on Siglec‐E on DCs and eosinophils. We first showed that Sigle‐E was expressed on cutaneous DCs and migratory DCs of draining lymph nodes. Moreover, OX40L expression on cutaneous DCs was reduced in the presence of Siglec‐E. In vitro experiments using cultured spleen DCs (SpDCs), highly expressing Siglec‐E, revealed that IL‐33 was involved in the induction of Siglec‐E and confirmed that Siglec‐E inhibited OX40L expression on SpDCs induced by IL‐33. Moreover, CD4 + T cell–SpDC coculture revealed that Siglec‐E inhibited Th2 polarisation under IL‐33 stimulation. We finally revealed that Siglec‐E was expressed on eosinophils and reduced the eosinophils infiltration to the MC903‐treated ear skin with the suppression of CD49d, a necessary integrin for eosinophil migration to skin tissue [1], expression on eosinophils. These findings elucidated the inhibitory role of Siglec‐E in MC903‐induced AD.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Dermatology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.
- Laboratory for Experimental Animals, Kyoto Prefectural University of Medicine, Kyoto, Japan.
- North Campus, Kyoto Prefectural University of Medicine, Kyoto, Japan.
ORCID profiles: Mari Nakanishi, Risa Tamagawa-Mineoka, Hiromi Nishigaki, Yukiyasu Arakawa, Satoshi Ohtsuka, Norito Katoh
Funding
- Public Promoting Association Asano Foundation for Studies on Medicine
- Japanese Ministry of Education, Science, Sports, and Culture
Cite
APA
Nakanishi, M., Tamagawa-Mineoka, R., Nishigaki, H., Arakawa, Y., Ohtsuka, S., & Katoh, N. (2025). Role of Siglec‐E in MC903 ‐Induced Atopic Dermatitis. Experimental Dermatology. https://doi.org/10.1111/exd.70064
Vancouver
Nakanishi M, Tamagawa-Mineoka R, Nishigaki H, Arakawa Y, Ohtsuka S, Katoh N. Role of Siglec‐E in MC903 ‐Induced Atopic Dermatitis. Experimental Dermatology. 2025. doi:10.1111/exd.70064
BibTeX
@article{Nakanishi2025,
author = {Nakanishi, Mari and Tamagawa-Mineoka, Risa and Nishigaki, Hiromi and Arakawa, Yukiyasu and Ohtsuka, Satoshi and Katoh, Norito},
title = {Role of Siglec‐E in MC903 ‐Induced Atopic Dermatitis},
journal = {Experimental Dermatology},
year = {2025},
doi = {10.1111/exd.70064}
}
EUVIMED